Ovid Therapeutics Inc
Ovid Therapeutics Inc (OVID) Options Open Interest
OVID options open interest is 5,251 contracts. The 2-week average daily volume is 152 contracts across the chain.
Read more
Monitoring OVID open interest helps you see where real money is positioned on Ovid Therapeutics Inc's options and which strikes are attracting the most commitment from traders. Ovid Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor OVID options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising OVID options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Ovid Therapeutics Inc to settle.
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder.
The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where OVID open interest is concentrated. Our scanner maps Ovid Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Ovid Therapeutics Inc's options open interest as the signal it is, not as an afterthought.
| 2.50 | 0.20 | 0.75 | 0.48 | 122% | +0.6850 | 1,280 |
| 5.00 | — | 0.05 | 0.05 | 161% | +0.1079 | 935 |
| 7.50 | — | 0.10 | 0.10 | 271% | +0.1359 | 120 |
| 1.50 | 0.65 | 1.65 | 1.15 | 29% | +1.0000 | 50 |
| 2.00 | 0.70 | 0.90 | 0.80 | 106% | +0.9099 | 45 |
| 2.50 | — | 0.10 | 0.10 | 78% | -0.2700 | 814 |
| 1.50 | — | 1.00 | 1.00 | 905% | -0.0781 | 136 |
| 2.00 | — | 0.15 | 0.15 | 180% | -0.1745 | 87 |
| 1.00 | — | 1.00 | 1.00 | 1,000% | -0.0471 | 9 |
| 0.50 | — | 0.05 | 0.05 | 490% | -0.0230 | 0 |
As of September 22, 2026
Follow the money
Track OVID open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→